Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis
- Paracha, N.
- Reyes, A.
- Diéras, V.
- Krop, I.
- Pivot, X.
- Urruticoechea, A.
ISSN: 1573-7217, 0167-6806
Año de publicación: 2020
Volumen: 180
Número: 3
Páginas: 597-609
Tipo: Revisión
